CD40 ligation restores type 1 polarizing capacity in TLR4-activated dendritic cells that have ceased interleukin-12 expression

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 1741-1750

  Michael Dohnal, Alexander ^a,b   Luger, Romana ^a   Paul, Petra ^a   Fuchs, Dietmar ^c   Felzmann, Thomas ^a,b  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b Trimed Biotech   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

CD40L; Cytokine exhaustion; Human dendritic cells; IL 10; IL 12; LPS; TH1 polarization; Tumour immunity

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 12; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL POLARITY; DENDRITIC CELL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; IMMUNOLOGY; METABOLISM; MIXED LYMPHOCYTE CULTURE; SIGNAL TRANSDUCTION;

ANTIGENS, CD40; CELL POLARITY; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-12; LYMPHOCYTE CULTURE TEST, MIXED; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 72949121261     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00584.x     Document Type: Article

References (32)

1. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006 311 : 17 58.
2. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004 4 : 499 511.
3. Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol. 1994 12 : 991 1045.
4. Felzmann T, Huttner KG, Breuer SK, et al. Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses. Cancer Immunol Immunother. 2005 54 : 769 780.
5. Hüttner KG, Breuer SK, Paul P, et al. Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells. Cancer Immunol Immunother. 2005 54 : 67 77.
6. Dohnal A, Witt V, Hugel H, et al. Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer. Cytotherapy. 2007 : 1 16.
7. Langenkamp A, Messi M, Lanzavecchia A, et al. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol. 2000 1 : 3116.
8. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol. 2004 4 : 762 774.
9. Hill M, Tanguy-Royer S, Royer P, et al. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells. Eur J Immunol. 2007 37 : 3054 3062.
10. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004 25 : 280 288.
11. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007 7 : 353 364.
12. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 2007 447 : 972 978.
13. Huang Q, Liu D, Majewski P, et al. The plasticity of dendritic cell responses to pathogens and their components. Science. 2001 294 : 870 875.
14. Covert MW, Leung TH, Gaston JE, et al. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science. 2005 309 : 1854 1857.
15. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003 3 : 133 146.
16. Rock KL, York IA, Goldberg AL. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat Immunol. 2004 5 : 670 677.
17. Lanzavecchia A. Immunology. Licence to kill. Nature. 1998 393 : 413 414.
18. Bennett SR, Carbone FR, Karamalis F, et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 1998 393 : 478 480.
19. Ridge JP, Di-Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998 393 : 474 478.
20. Schoenberger SP, Toes RE, van-der-Voort EI, et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998 393 : 480 483.
21. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol. 2001 2 : 725 731.
22. Dohnal AM, Graffi S, Witt V, et al. Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines. J Cell Mol Med. 2009 13 : 125 135.
23. Shapiro DN, Valentine MB, Rowe ST, et al. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am J Pathol. 1993 142 : 1339 1346.
24. Laich A, Neurauter G, Widner B, et al. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem. 2002 48 : 579 581.
25. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 2007 7 : 19 30.
26. Macagno A, Napolitani G, Lanzavecchia A, et al. Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol. 2007 28 : 227 233.
27. Logue EC, Sha WC. CD28-B7 bidirectional signaling: a two-way street to activation. Nat Immunol. 2004 5 : 1103 1105.
28. Puccetti P. On watching the watchers: IDO and type I/II IFN. Eur J Immunol. 2007 37 : 876 879.
29. West MA, Heagy W. Endotoxin tolerance: a review. Crit Care Med. 2002 30 : S64 73.
30. Kalinski P, Schuitemaker JHN, Hilkens CMU, et al. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-{gamma} and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J Immunol. 1999 162 : 3231 3236.
31. Felzmann T, Buchberger M, Lehner M, et al. Functional maturation of dendritic cells by exposure to CD40L transgenic tumor cells, fibroblasts or keratinocytes. Cancer Lett. 2001 168 : 145 154.
32. Kajino K, Nakamura I, Bamba H, et al. Involvement of IL-10 in exhaustion of myeloid dendritic cells and rescue by CD40 stimulation. Immunology. 2007 120 : 28 37.